If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Product Launch » Product Launch Excellence
Download FREE Excerpt
68 Info Graphics
28 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Biotech; Medical Device; Biopharmaceutical; Laboratories; Clinical Research; Health Care; Manufacturing; Consumer Products; Diagnostic; Consulting; Chemical; Public Relations; Media; Technology; Communications; Computer Software; Telecommunications; Research; Medical; Professional Services; Science; Marketing
Abbott Laboratories; Abbvie; Actavis; Actelion; Adamas Pharmaceuticals; ADC Therapeutics; Advanced Accelerator Applications; AeroGen; Agios; Aimmune Therapeutics; Alcon Laboratories; Alexion Pharmaceuticals; Align Technology; Alkem; Alkermes; Allergan; Almirall; Alnylam Pharmaceuticals; AMAG Pharmaceuticals; Amgen; Amicus Therapeutics; Amylin; Apellis Pharmaceuticals; Apex Pharma; Aptus Clinical; Arena Pharmaceuticals; Ascend Therapeutics; Ascensia; Asklepion Pharmaceuticals; Aspen Pharmacare; Astellas; AstraZeneca; Atara Biotherapeutics; Avadel Pharmaceuticals; Avanir; Avant Healthcare; Avantor Performance Materials; B. Braun; Baxalta; Baxter Healthcare; Bayer; Berlex Laboratories; Biocon; BioDelivery Sciences International; Biofrontera; Biogen; Boehringer Ingelheim; Bracco Diagnostics Inc.; Braeburn; Bristol-Myers Squibb; Cadila Pharmaceuticals; Caldera; Canopy Growth; Cara Therapeutics; Cascadia Drug Development Group; Catalyst Pharmaceuticals; Cegedim; Celgene; Celyad; Centocor Ortho Biotech Inc.; Cephalon; Chiesi; Cipla; Cofactor Group; Consensus Orthopedics; ConvaTec; Crown Laboratories; CSL Behring; Cubist Pharmaceuticals; Daiichi Sankyo; DBV Tehcnologies; Deciphera Pharmaceuticals; Dendreon Pharmaceuticals LLC; DiaSorin; Dr Reddy's Laboratories; Eagle Pharmaceuticals; Egis; EHOB; Eisai; Eli Lilly and Company; EMD Serono; eNeura Therapeutics; Ethypharm; EyePoint Pharmaceuticals; FerGene; Ferozsons Laboratories Limited; Ferring Pharmaceuticals; FleishmanHillard; Frankel Advisory Group LLC; Fresenius Medical Care AG & Co. KGaA; Galderma; GE Healthcare; Genentech; Genmab; Genzyme; Getz Pharma; GlaxoSmithKline; Greenwich Biosciences; Grifols; Grünenthal; Guerbet; Halloran Consulting Group; Helsinn; Horizon Therapeutics; Hospira; IDbyDNA; Idorsia; IDS Canada; Indivior; Ipsen; Iridex; Ironwood; Janssen; Joerns Healthcare; Johnson & Johnson; Kala Pharmaceuticals; Kaleo; Karyopharm Therapeutics; Kiniksa Pharmaceuticals; Kyowa Kirin; Laboratorios Deramtologicos Darier; Leica Biosystems; LeMaitre Vascular; LEO Pharma; Lilly; Linde; Lundbeck; Lupin; Mallinckrodt; Mayne Pharma; Meda Pharmaceuticals; Medacta USA; Medexus Pharmaceuticals; Medicure; MedImmune; MedinCell; Medis; MEDiSTRAVA; Medrad; Medrobotics; Medtronic; Melinta Therapeutics; Merck; Merck KGaA; Merial; Milestone Pharmaceuticals; Mint Pharmaceuticals Inc.; Mirador Global LP; Mission Bio; moksha8; Monebo Technologies; MSD; Nabriva Therapeutics; Nestle Health Science; Nevakar; NexGen Healthcare Communications; Nobio; Novartis; Novo Nordisk; Nuvisan; Ora; Organon; Ortho-McNeil; Osmotica Pharmaceuticals; OTSUKA; Panacea Biotec; Paratek Pharmaceuticals; PerkinElmer; Pfizer; Pharmacia; Piramal Group; Prime Global; ProCaps Laboratories; Prometheus Therapeutics & Diagnostics; Proteus Digital Health; Purdue Pharma; QED Therapeutics; Quintiles; RECKITT BENCKISER; Retrophin; Rigel Pharmaceuticals; Roche; Samumed; Sandoz; Sanofi; Sanofi Genzyme; Sanofi Pasteur; Sanofi-aventis; Santen; Santhera Pharmaceuticals; Sarah Cannon; Schering-Plough; Scilex Pharmaceuticals; Servier; Shionogi Inc.; Shire; Sivantos Pte. Ltd.; SK Life Science; Smith & Nephew; Solvay Pharmaceuticals; SomaGenics Inc; Stgilesmedical London & Berlin; Straumann; Sumitovant BioPharma; Sunovion; Supernus; Surrozen; Synapse biomedical; Syneos Health; Takeda Pharmaceuticals; Talecris; Taro; TEAMM Pharmaceuticals; Tecan; TerSera Therapeutics; Teva Neuroscience; Teva Pharmaceutical Industries Ltd; TG Therapeutics; The Medical Affairs Company; The Stem; Theravance; Thermo Fisher Scientific; Ther-Rx; Think Surgical; Thompson Surgical Instruments; Tiber Laboratories; Tibotec; Tibotec-Virco; Tokai Pharmaceuticals; UCB Pharma; unichem; United BioSource; Upsher-Smith; Vertex Pharmaceuticals; Vifor Pharma; ViiV Healthcare; Visioneering Technologies Inc.; Wellspect HealthCare; West 53rd St Digital; Worldwide Clinical Trials; XACT Robotics; Xanodyne Pharmaceuticals; XG Sciences; Zeiss Pharma; Zosano Pharma; ZS Pharma; Zydus Cadila
Best Practices, LLC employed a four-step approach in conducting this meta-analysis. Phase I involved search around key physician engagement areas, phase II involved a detailed probe of 18 of our benchmark studies, data was harvested in phase III to develop insights, and phase IV involved the organization of insights in a framework.
Key topics covered in this report include: